Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
|Articles|May 27, 2022
News Roundup: May 23 to May 27
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Examining the Professional Landscape for Pharmacy Techs
The scope of practice for pharmacy techs has changed in recent years, allowing for greater responsibilities, and the current labor shortage poses some challenges.
New Formulation Approval Patterns Indicate “Evergreening” by Drugmakers
Findings in show that new formulations were more likely for blockbuster drugs and drugs that received accelerated approval. Proxy measures of clinical usefulness and other elements of therapeutic value were not associated with new formulations.
Favorable Response to Third Dose of Pfizer-BioNTech Vaccine Noted for Kids 6 Months to 5 Years
Pfizer-BioNTech reports strong immune response, high efficacy, and favorable safety in third dose of the COVID-19 vaccine.
Examining the Impact of Sleep Deprivation in Eye Disease
Researchers may have identified a potential solution.
Antibiotics Linked to Higher IBD Risk in Older Adults
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
Advertisement
Related to this article
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
Advertisement
Advertisement
Trending on Drug Topics
1
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
2
Early CGMs Results in Better 5-Year Glucose Control in Type 1 Diabetes
3
Polypharmacy, Drug Interactions Threaten Older Adults’ Medication Safety
4
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
5